Karile Cristina da Costa Salomão

Karile Cristina da Costa Salomão

Auto-generated profile, based on publicly available information

Karile Cristina da Costa Salomão

Department of Morphological Science, State University of Maringá, Maringá 87020-900, PR, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MARIANA CONCEIÇÃO DA SILVAMARIANA CONCEIÇÃO DA SILVA
MARIANA CONCEIÇÃO DA SILVA
LFLilian Catarim Fabiano
Lilian Catarim Fabiano
KSKarile Cristina da Costa Salomão
Karile Cristina da Costa Salomão
PFPedro Luiz Zonta de Freitas
Pedro Luiz Zonta de Freitas
CNCamila Quaglio Neves
Camila Quaglio Neves
NBNilza Cristina Buttow
Nilza Cristina Buttow
5-Fluorouracil (5-FU) is a chemotherapy drug widely used to treat a range of cancer types, despite the recurrence of adverse reactions. Therefore, information on its side effects when administered at a clinically recommended dose is relevant. On this basis, we examined the effects of the 5-FU clinical treatment on the integrity of the liver, kidneys, and lungs of rats. For this purpose, 14 male Wistar rats were divided into treated and control groups and 5-FU was administered at 15 mg/kg (4 consecutive days), 6 mg/kg (4 alternate days), and 15 mg/kg on the 14th day. On the 15th day, blood, liver, kidney, and lung samples were collected for histological, oxidative stress, and inflammatory evaluations. We observed a reduction in the antioxidant markers and an increase in lipid hydroperoxides (LOOH) in the liver of treated animals. We also detected elevated levels of inflammatory markers, histological lesions, apoptotic cells, and aspartate aminotransferase. Clinical treatment with 5-FU did not promote inflammatory or oxidative alterations in the kidney samples; however, histological and biochemical changes were observed, including increased serum urea and uric acid. 5-FU reduces endogenous antioxidant defenses and increases LOOH levels in the lungs, suggesting oxidative stress. Inflammation and histopathological alterations were also detected. The clinical protocol of 5-FU promotes toxicity in the liver, kidneys, and lungs of healthy rats, resulting in different levels of histological and biochemical alterations. These results will be useful in the search for new adjuvants to attenuate the adverse effects of 5-FU in such organs.